After a coronary stent is implanted, symptoms often disappear and daily life returns to normal — but stenting is the beginning of treatment, not the end. Published literature suggests that roughly one in ten patients may develop in-stent restenosis. Narrowing and reduced blood supply to the heart muscle can also develop silently, without chest tightness or pain, which is why follow-up relies on imaging rather than on how a patient feels.

A Patient's Dilemma: One Scan Instead of an Invasive Procedure

A 63-year-old woman, one and a half years after coronary stenting and living with well-controlled hypertension on regular medication, had no chest symptoms but remained concerned about restenosis. Conventional invasive follow-up would have required hospitalization and arterial puncture, with pain, radiation exposure and a risk of vascular injury. A standard coronary CTA could show the outer shape of the stent but could not tell whether the downstream heart muscle was short of blood. She therefore chose a non-invasive coronary CTA + FFR assessment.

The combined assessment showed a patent stent, only mild plaque and no myocardial ischemia. Two specialists reviewing the findings together concluded that invasive catheter angiography was not needed; she continued her prescribed medication and scheduled follow-up.

The Real Limits of Current Follow-Up Options

In-stent restenosis remains a recognized complication after PCI, and missed follow-up can leave risks undetected. Two commonly used approaches each have limitations:

  • DSA is a reference standard for assessing the vessel lumen, but it is invasive: arterial puncture, local swelling and infection risk, hospitalization and higher cost make it unsuitable for repeated routine follow-up.
  • Standard coronary CTA shows the stent, plaque and vessel narrowing, but metal artifacts limit it to anatomy; it cannot assess myocardial ischemia and is less reliable for moderate lesions.

One Scan, Two Dimensions: Anatomy and Function

Coronary CTA + FFR obtains structural and functional information from a single CT acquisition.

  • Structural assessment — stent morphology, in-stent restenosis, degree of stenosis, plaque characteristics and calcium scoring.
  • Functional assessment — CT-FFR non-invasively estimates fractional flow reserve, evaluates myocardial blood supply, identifies ischemic lesions and supports follow-up and medication planning.

Evidence and Equipment

Invasive FFR is the reference standard for functional assessment of coronary lesions, and its clinical value is recognized by the American Heart Association, the European Society of Cardiology and Chinese expert consensus. CT-FFR is a non-invasive simulation technique with approximately 90% accuracy against invasive FFR (sensitivity 90.5%, specificity 89.7%), and can serve as a pre-screening tool. A multicenter prospective study of a CT-FFR system led by the teams of Academicians Ge Junbo and Wang Jian'an was published in the European Heart Journal and validated across multiple Chinese hospitals.

On a high-slice-count CT scanner, the acquisition can be completed within a single heartbeat, so most patients do not need medication to lower their heart rate. Thin-slice imaging keeps stents and plaque clearly visible, and the low radiation dose makes repeat examinations less of a concern.

Two Specialists, One Report

Imaging specialists and cardiologists interpret the examination jointly, considering medical history, prior procedures, blood pressure and lipid profiles to advise on the need for angiography, follow-up intervals, medication and lifestyle — always together with the treating physician.

A Non-Invasive First Step

Coronary CTA + FFR offers a non-invasive first-line follow-up pathway after stenting. It is an imaging-based adjunct that can help detect in-stent restenosis and myocardial ischemia earlier; if either is suggested, coronary angiography can then be considered. Regular follow-up, adherence to prescribed medication and healthy habits together support long-term cardiovascular health.

This article is general health information based on a case-sharing example and is not medical advice. Any post-processing data analysis report is based on the images from that examination and the information provided, is for clinical reference only, and the final imaging diagnostic report prevails. Please follow your treating physician's instructions for any examination or treatment decision, and consult a qualified clinician before changing medication or follow-up plans.

References

  • [1] Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States.
  • [2] Chinese guidelines for the diagnosis and treatment of intracranial atherosclerotic stenosis.
  • [3] Chinese expert consensus on CT examination and diagnosis of coronary artery disease.
  • [4] Prospective multicenter clinical trial, Peking University Clinical Research Institute.